Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Itacitinib adipate | 1334302-63-4 | 99.2% | 699.66 | 50 MG
SDP

Catalog No. 5000393579
Encompass_Preferred

Itacitinib adipate is an orally bioavailable and selective JAK1 inhibitor which has been tested for efficacy and safety in a phase II trial in myelofibrosis.

  • Orally bioavailable and selective JAK1 inhibitor.
  • Evaluated in phase II clinical trials for myelofibrosis.
  • Available in various quantities and solution formats.
  • High purity.
  • Involved in numerous clinical trials for various conditions including Acute Lymphoblastic Leukemia, Systemic Sclerosis, Graft-versus-host Disease, and various cancers.

Catalog No. 50-003-93579 Supplier Medchemexpress LLC Supplier No. HY16997A50MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Itacitinib adipate is an orally bioavailable and selective JAK1 inhibitor which has been tested for efficacy and safety in a phase II trial in myelofibrosis.

  • Orally bioavailable and selective JAK1 inhibitor.
  • Evaluated in phase II clinical trials for myelofibrosis.
  • Available in various quantities and solution formats.
  • High purity.
  • Involved in numerous clinical trials for various conditions including Acute Lymphoblastic Leukemia, Systemic Sclerosis, Graft-versus-host Disease, and various cancers.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.